Spiral Therapeutics
PrivateLast Round
Series B
Apr 14, 2026
Total Funding Raised
$32.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Spiral Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series B round in April 2026.
Spiral Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for inner ear disorders using its proprietary Minimally Invasive Cochlear System (MICS™) drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spiral Therapeutics Comparables
Compare Spiral Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strekin AG | 85% | |
| Acousia Therapeutics GmbH | 83% | |
| AudioCure Pharma | 80% |
For institutional investors. Book with your work email.
Spiral Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 14, 2026 | ||||
| VC Round | Aug 30, 2023 | ||||
| VC Round | Jan 9, 2023 | ||||
| Series A | May 6, 2019 |
For institutional investors. Book with your work email.
Spiral Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ferring Ventures SA | Series B, VC Round |
| Esperante Ventures | VC Round |
| Inveready | Series A |
| Savoir Capital | Series A, VC Round |
| Catalio Capital Management | VC Round |
| Humboldt Fund | VC Round |
| Esperante | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 96% MoM.
- Jun 21, 2026
Monthly visitors increased 31% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Spiral Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spiral Therapeutics's valuation, stock price, and market status.
Is Spiral Therapeutics a public or private company?
Spiral Therapeutics is a private company.
What is the current stock price of Spiral Therapeutics?
Spiral Therapeutics is a private company, so its shares have no public market price. Caplight tracks Spiral Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spiral Therapeutics worth (valuation)?
Valuation information for Spiral Therapeutics is not publicly available.
Can I buy Spiral Therapeutics stock?
Spiral Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spiral Therapeutics's last funding round?
Spiral Therapeutics's most recent funding round was Series B on April 14, 2026.
Who are the main investors in Spiral Therapeutics?
Key investors in Spiral Therapeutics include Ferring Ventures SA, Esperante Ventures, Savoir Capital, Catalio Capital Management, Esperante.
Will Spiral Therapeutics IPO soon?
No public IPO plans have been announced for Spiral Therapeutics.
How can I track Spiral Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Spiral Therapeutics's shares on secondary markets.